Inhaled simvastatin nanoparticles for inflammatory lung disease.
Sign Up to like & getrecommendations! Published in 2017 at "Nanomedicine"
DOI: 10.2217/nnm-2017-0188
Abstract: AIM Current inhaled treatments are not adequate to treat all lung diseases. In this study, a promising nanotechnology has been developed to deliver a potential anti-inflammatory and muco-inhibitory compound, simvastatin, for treatment of inflammatory lung… read more here.
Keywords: inflammatory lung; nanoparticles inflammatory; simvastatin nanoparticles; inhaled simvastatin ... See more keywords